EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

September 18, 2023Kristi RosaThe European Medicines Agency has granted Priority Medicines designation to iopofosine I-131 for use in patients with Waldenström macroglobulinemia in patients who previou

Updated on: October 11,2023

EMA Grants PRIME Designation to Iopofosine I-131 for Waldenström Macroglobulinemia

September 18, 2023Kristi RosaThe European Medicines Agency has granted Priority Medicines designation to iopofosine I-131 for use in patients with Waldenström macroglobulinemia in patients who previou

Updated on:October 11,2023

Skin cancer: More people die from types that aren't melanoma, says surprise new finding

by Sarah Allinson,The ConversationCredit: AI-generated imageIf you mention skin cancer, most people think of melanoma—the deadliest skin cancer. The other ones are pretty benign, right?Not so. W

Updated on: October 31,2023

Skin cancer: More people die from types that aren't melanoma, says surprise new finding

by Sarah Allinson,The ConversationCredit: AI-generated imageIf you mention skin cancer, most people think of melanoma—the deadliest skin cancer. The other ones are pretty benign, right?Not so. W

Updated on:October 31,2023

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co

Updated on: December 21,2023

New potential therapeutic approach for HER2-positive breast cancer discovered

by Leibniz Research Centre for Working Environments and Human Factors in DortmundEDI3 expression and enzyme activity according to HER2 and ER status. A, EDI3 (GPCPD1; 224826_at) mRNA expression was co

Updated on:December 21,2023

Success of Rhabdomyosarcoma Treatment in Children

Including Rarer Types of RMS Disease in AdultsByJaime R. Herndon, MS, MPHPublished on July 03, 2023Medically reviewed byDoru Paul, MDRhabdomyosarcomais a kind ofsar

Updated on: November 21,2023

Success of Rhabdomyosarcoma Treatment in Children

Including Rarer Types of RMS Disease in AdultsByJaime R. Herndon, MS, MPHPublished on July 03, 2023Medically reviewed byDoru Paul, MDRhabdomyosarcomais a kind ofsar

Updated on:November 21,2023

SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

Damian McNamara, MAVANCOUVER, Canada — Use of sodium glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancers among patients withtype 2 diabe

Updated on: October 27,2023

SGLT2 Inhibitors in Type 2 Diabetes Linked to Lower Risk of Developing GI Cancers

Damian McNamara, MAVANCOUVER, Canada — Use of sodium glucose cotransporter-2 (SGLT2) inhibitors is associated with a reduced risk of gastrointestinal (GI) cancers among patients withtype 2 diabe

Updated on:October 27,2023

Gene linked to glioblastoma stem cell self-renewal and immunosuppression

by Olivia Dimmer,Northwestern UniversityWorking model. a, Illustration shows a proposed mechanism for the TFPI2 and its associated signaling axis in regulating self-renewal of glioma stem cells

Updated on: October 31,2023

Gene linked to glioblastoma stem cell self-renewal and immunosuppression

by Olivia Dimmer,Northwestern UniversityWorking model. a, Illustration shows a proposed mechanism for the TFPI2 and its associated signaling axis in regulating self-renewal of glioma stem cells

Updated on:October 31,2023

What to Know About Blood Typing

What to Know About Blood TypingByNancy LeBrunPublished on July 14, 2023Medically reviewed bySteffini Stalos, DOYourblood typeis categorized by certain substances on

Updated on: March 17,2024

What to Know About Blood Typing

What to Know About Blood TypingByNancy LeBrunPublished on July 14, 2023Medically reviewed bySteffini Stalos, DOYourblood typeis categorized by certain substances on

Updated on:March 17,2024

New study disentangles a long-standing link between inflammation and cancer progression

byUniversity of OxfordCredit: AI-generated imageA new study published inNature Geneticsled by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unk

Updated on: October 31,2023

New study disentangles a long-standing link between inflammation and cancer progression

byUniversity of OxfordCredit: AI-generated imageA new study published inNature Geneticsled by the Mead Group in the Radcliffe Department of Medicine has demonstrated a previously unk

Updated on:October 31,2023

Liver cancer: Risk factors and prevention

by Laurel Kelly,Mayo ClinicCredit: Pixabay/CC0 Public DomainOctober is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you c

Updated on: October 31,2023

Liver cancer: Risk factors and prevention

by Laurel Kelly,Mayo ClinicCredit: Pixabay/CC0 Public DomainOctober is Liver Cancer Awareness Month, which makes this a good time to learn more about risk factors for liver cancer and what you c

Updated on:October 31,2023

Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

byDana-Farber Cancer InstituteInfant high-grade glioma. Credit: David Ellison, St. Jude Children’s Research HospitalIn order to accurately assess the efficacy of novel therapies for brain tumors

Updated on: October 31,2023

Single set of criteria to assess progression in glioma aims to speed discovery of new medicines

byDana-Farber Cancer InstituteInfant high-grade glioma. Credit: David Ellison, St. Jude Children’s Research HospitalIn order to accurately assess the efficacy of novel therapies for brain tumors

Updated on:October 31,2023

α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC

Updated on: November 28,2024

α-KG-dependent glycolysis activation by BCAT1 contributes to EGFR-TKI resistance in NSCLC

Updated on:November 28,2024

AI tool reveals cardiac risk for patients undergoing cancer therapy

byYale School of MedicineBaseline AI-ECG screening for LVSD and all-cause mortality risk. Adjusted cumulative hazard curves for all-cause mortality stratified by the AI-ECG LVSD probability. Cre

Updated on: September 27,2024

AI tool reveals cardiac risk for patients undergoing cancer therapy

byYale School of MedicineBaseline AI-ECG screening for LVSD and all-cause mortality risk. Adjusted cumulative hazard curves for all-cause mortality stratified by the AI-ECG LVSD probability. Cre

Updated on:September 27,2024